RVL Pharmaceuticals to Host UPNEEQ® Overview and Business Update Webcast on January 19, 2022
Osmotica Pharmaceuticals plc (NASDAQ: OSMT) announced a video webcast on January 19, 2022, hosted by CEO Brian Markison and COO James Schaub.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Osmotica Pharmaceuticals plc (NASDAQ: OSMT) announced a video webcast on January 19, 2022, hosted by CEO Brian Markison and COO James Schaub. They will share insights on UPNEEQ® trends, the company's expansion plans into the medical aesthetics market, and other business updates. Featured speakers include Dr. Jackie Yee, a specialist in Aesthetic Injectables, and Dr. Justin Harper, an Aesthetic Physician. The webcast begins at 8:30 a.m. ET and will be available later on the company's website.
Osmotica is known for UPNEEQ®, the first FDA-approved non-surgical treatment for acquired blepharoptosis.
Details
News Market Reaction – OSMT
The recorded move for OSMT in the trading session of this news was -1.77%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
-- Topics include corporate name change, launch plans into the medical aesthetics market and general business updates --
-- Featured speakers include Dr. Jackie Yee and Dr. Justin Harper --
Bridgewater, N.J., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (NASDAQ: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, announced today that Brian Markison, Chief Executive Officer and James “JD” Schaub, Chief Operating Officer, will host a video webcast to discuss recent UPNEEQ® trends, pending expansion into the medical aesthetics market and other general business updates.
Dr. Jackie Yee is board-certified in Plastic and Reconstructive Surgery and specializes in Aesthetic Injectables and Cosmetic Surgery based in Miami, Florida.
Dr. Justin Harper is an Aesthetic Physician and healthcare innovator with a diverse background encompassing plastic surgery, dermatology, and medical technology based in Columbus, Ohio.
Webcast details are as follows:
| Date: | Wednesday, January 19, 2022 |
| Time: | 8:30 a.m. ET |
| Webcast: | https://experience.v-unite.com/#/aestheticrecorddemo/rvlinvestorday/room/welcome |
The webcast will be available thereafter via the Company’s website at www.rvlpharma.com under the “Investor & News” section.
About RVL Pharmaceuticals plc
RVL Pharmaceuticals plc is a specialty pharmaceutical company focused on the commercialization and development of products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas. The Company is currently commercializing UPNEEQ® (oxymetazoline hydrocholoride ophthalmic solution),
Investor and Media Relations for RVL Pharmaceuticals plc
Lisa M. Wilson
In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.